Prof. K. Bhatia

Clinical Movement Disorders Group

Lab Head: Professor Kailash Bhatia

Clinical trials of:

• rotigotine dopamine agonist patch in Parkinson’s disease (PD)

• synthetic human growth hormone in multiple system atrophy (MSA)

• riluzole in MSA and progressive supranuclear palsy (PSP).

• National PD-SURG trials in PD

• London/Lund/Marburg programme of fetal nigral mesencephalic grafting in PD.

• Development of MSA rating scale and therapeutic trial assessment protocols, and of Quality of Life scales for MSA and PSP.

Clinical research projects on:

• repetitive transcranial magnetic stimulation (rTMS) in movement disorders

• the syndrome of fixed dystonia

• DYT1 gene carriers with and without dystonia

Group members

Prof. Kailash Bhatia MD, DM, FRCP k.bhatia{at}ion.ucl.ac.uk

Dr Caroline Selai MSc, PhD c.selai{at}ion.ucl.ac.uk

Collaborations:

1 Other research departments in the Institute of Neurology

2 MRC Cyclotron Unit (Prof D J Brooks), RPMS, Hammersmith Hospital

3 European MSA Study Group (www.EMSA-SG.org)

4 Wallenberg Neuroscience Centre, Lund University, Sweden

5 European Dystonia Epidemiology Group

Page last modified on 07 may 10 08:58